Suppr超能文献

口服抗坏血酸铜对葡萄糖耐量试验无影响。

Noneffect of oral urinary copper ascorbic acid on reduction glucose test.

作者信息

Nahata M C, McLeod D C

出版信息

Diabetes Care. 1978 Jan-Feb;1(1):34-5. doi: 10.2337/diacare.1.1.34.

Abstract

References and texts in the fields of diabetes and clinical chemistry commonly report that ascorbic acid when given orally or parenterally gives a false-positive reaction to the copper reduction glucose test (Clinitest). This impression is based on a study in which ascorbic acid (250 mg./dl.) was added to urine in vitro, with a resultant positive-test reading in the absence of glucose. Ascorbic acid is a reducing agent, and theoretically it could interfere with the copper reduction method of glucose detection. In the current study 10 nondiabetic men were ingesting 4 and 6 gm. ascorbic acid per day. A total of 360 glucose detection tests with the copper reduction method were undertaken. In no instance was there a positive reaction to the glucose test.

摘要

糖尿病和临床化学领域的参考文献及文本通常报道,口服或肠胃外给予抗坏血酸会使铜还原葡萄糖试验(Clinitest)出现假阳性反应。这种观点基于一项研究,该研究将抗坏血酸(250毫克/分升)在体外添加到尿液中,结果在无葡萄糖的情况下检测结果呈阳性。抗坏血酸是一种还原剂,理论上它可能会干扰葡萄糖检测的铜还原法。在当前研究中,10名非糖尿病男性每天摄入4克和6克抗坏血酸。总共进行了360次铜还原法葡萄糖检测试验。在任何情况下,葡萄糖检测均未出现阳性反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验